BIRC5 and nasopharyngeal carcinoma: Previous studies identified that miR-218 inhibited invasion and metastasis of gastric cancer by targeting the Robo1 receptor and suppressed nasopharyngeal cancer progression through the downregulation of survivin and the Slit2-Robo1 pathway (16,17).